Biofourmis Biovitals

Biofourmis Biovitals is a leading enterprise-grade AI platform designed for high-acuity remote patient monitoring and decentralized clinical trials. Its 2026 market positioning focuses on 'Hospital-at-Home' orchestration, utilizing its FDA-cleared Biovitals Analytics Engine. The architecture leverages a sophisticated sensor-agnostic data ingestion layer that processes continuous physiological data (ECG, SpO2, heart rate, respiration) via proprietary machine learning models. Unlike reactive monitoring tools, Biovitals identifies clinical decompensation up to 21 hours before a critical event by establishing a personalized physiological baseline for each patient. By 2026, the platform has evolved to include generative AI interfaces for clinician charting and automated patient engagement loops. It operates as a full-stack solution, combining wearable hardware integration, a cloud-native analytics backend, and a dedicated clinical dashboard. The system is designed to reduce hospital readmissions by 38% and lower the cost of care for complex chronic conditions like heart failure and COPD. Its API-first design allows seamless bidirectional data flow with major EHR systems like Epic and Cerner, ensuring it fits within existing clinical workflows.